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Abstract
AIM
To investigate the accuracy of fungal dysbiosis in 
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mucosa and stool for predicting the diagnosis of Crohn’s 
disease (CD). 
METHODS
Children were prospectively enrolled in two medical 
centers: one university hospital and one private 
gastroenterology clinic in the city of Riyadh, Kingdom 
of Saudi Arabia. The children with confirmed diagnosis 
of CD by standard guidelines were considered cases, 
and the others were considered non-inflammatory 
bowel disease controls. Mucosal and stool samples 
were sequenced utilizing Illumina MiSeq chemistry 
following the manufacturer’s protocols, and abundance 
and diversity of fungal taxa in mucosa and stool were 
analyzed. Sparse logistic regression was used to predict 
the diagnosis of CD. The accuracy of the classifier was 
tested by computing the receiver operating characteristic 
curves with 5-fold stratified cross-validation under 100 
permutations of the training data partition and the 
mean area under the curve (AUC) was calculated. 
RESULTS
All the children were Saudi nationals. There were 15 
children with CD and 20 controls. The mean age was 
13.9 (range: 6.7-17.8) years for CD children and 13.9 
(3.25-18.6) years for controls, and 10/15 (67%) of 
the CD and 13/20 (65%) of the control subjects were 
boys. CD locations at diagnosis were ileal (L1) in 4 
and colonic (L3) in 11 children, while CD behavior was 
non-stricturing and non-penetrating (B1) in 12 and 
stricturing (B2) in 3 children. The mean AUC for the 
fungal dysbiosis classifier was significantly higher in 
stools (AUC = 0.85 ± 0.057) than in mucosa (AUC = 
0.71 ± 0.067) (P  < 0.001). Most fungal species were 
significantly more depleted in stools than mucosal 
samples, except for Saccharomyces cerevisiae  and 
S.  bayanus , which were significantly more abundant. 
Diversity was significantly more reduced in stools than 
in mucosa. 
CONCLUSION
We found high AUC of fungal dysbiosis in fecal samples of 
children with CD, suggesting high accuracy in predicting 
diagnosis of CD.
Key words: Fungiome; Mycobiome; Crohn’s disease; 
Inflammation; Saudi children
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Core tip: We found high accuracy of fungal dysbiosis in 
predicting diagnosis of Crohn’s disease (CD), a finding 
similar to bacterial dysbiosis. However, the higher area 
under the curve for the fungal dysbiosis classifier in 
stool (0.85 ± 0.057) than in mucosa (0.71 ± 0.067) (P 
< 0.001), contrasts with bacterial studies, suggesting 
higher accuracy of stool samples. Although the clinical 
application of this finding is limited at present by 
the high cost of fungal analysis, such information is 
important from a scientific viewpoint, to increase the 
understanding of the role of fungal flora in CD and to 
stimulate further studies.
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INTRODUCTION
Inflammatory bowel diseases (IBDs), including Crohn’s 
disease (CD) and ulcerative colitis, are chronic condi­
tions. Their incidence is highest, with an increasing trend, 
in Western populations[1,2]. However, their incidence is 
increasing in non­Western populations as well[3,4]. The 
cause of CD remains unknown despite extensive research, 
and a multifactorial etiology has been suggested. In 
genetically­susceptible individuals, environmental trigger­
ing factors play a major role and diet and microbiota are 
the most relevant causative factors for children[5]. Dietary 
components may act directly or through alteration of 
gut microbiota to initiate and maintain inflammation in 
susceptible subjects[6,7]. Significant fungal dysbiosis has 
been demonstrated in adults and children with CD[8­10]. 
Recent reports found high accuracy of bacterial dysbiosis 
in predicting the diagnosis of IBD in general and CD in 
particular[11­13]. 
Despite the demonstration of fungal dysbiosis in 
adults and children with CD, there are no similar reports 
on the potential role of fungal dysbiosis in the diagnosis 
of CD. The objective of this report was, therefore, to 
evaluate the accuracy of fungal dysbiosis in stool and 
mucosal samples, for the diagnosis of CD in a cohort of 
non­Western children with new onset disease. 
MATERIALS AND METHODS
Ethical considerations
This report is a portion of the main study project titled 
“Characteristics of inflammatory bowel disease in Saudi 
children”. The study was reviewed and approved by the 
Institutional Review Board of the College of Medicine, 
King Saud University. Riyadh, Kingdom of Saudi Arabia 
(Approval number: 10/2647/IRB).
Study population, sample collection, storage, and 
processing
Children were prospectively enrolled in two medical 
centers: One university hospital and one private 
gastroenterology clinic in the same city of Riyadh, 
Kingdom of Saudi Arabia. The children were referred 
to these clinics for investigation of suspected IBD. The 
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children with confirmed diagnosis of CD by standard 
guidelines[14] were considered cases and those in whom 
the diagnosis of CD was excluded were considered non­
IBD controls. The most common final diagnoses in 
non­IBD controls were functional abdominal pain and 
polyps. Mucosal and fecal samples were collected from 
15 children with confirmed CD and 20 controls without 
inflammation or infection. A total of 78 samples (58 
from CD children and 20 from non­IBD controls) were 
obtained. Stool samples were collected before bowel 
preparation, and none afterward. Mucosal forceps 
biopsies were taken from various parts of the colon 
and ileum. All samples were put into cryovials without 
preservatives and transported immediately in ice to the 
laboratory and stored at ­80 ℃. At the end of the study, 
all samples were shipped by express mail in dry ice to 
MRDNA Laboratories (Shallowater, TX, United States) 
for microbiome analysis. 
Fungal DNA extraction and sequencing
Fungal DNA was extracted using the Mobio PowerSoil kit 
as per the manufacturer’s instructions (Mobio, Carlsbad, 
CA, United States). Amplicon sequencing service 
(bTEFAP®) was performed at MRDNA Laboratories and 
used for the fungal analysis[15]. The internal transcribed 
spacer primers, ITS1F (CTTGGTCATTTAGAGGAAGTAA) 
and ITS2R (GCTGCGTTCTTCATCGATGC), were used. 
A single­step 30­cycle polymerase chain reaction (PCR 
with HotStart Taq Plus Master Mix kit (Qiagen, Valencia, 
CA, United States) was employed. Samples were 
sequenced utilizing Illumina MiSeq chemistry following 
the manufacturer’s protocols. 
The Q25 sequence data derived from the sequencing 
process was processed using the MRDNA ribosomal and 
functional gene analysis pipeline (www.mrdnalab.com). 
Sequences were depleted of barcodes and primers, short 
sequences of < 150 bp were removed, and sequences 
with ambiguous base calls were removed. Operational 
taxonomic units were defined by clustering at 3% 
divergence (97% similarity), followed by removal of 
singleton sequences and chimeras. Final operational 
taxonomic units were taxonomically classified using 
BLASTn top hit analysis against a curated database 
derived from RDPII and NCBI (http://rdp.cme.msu.
edu and www.ncbi.nlm.nih.gov, respectively) and 
compiled into each taxonomic level as both “counts” and 
“percentage” files. 
Statistical analysis
All analyses were performed using Python and scikit­
learn[16]. Custom functions implementing the permutation 
test were written to detect the taxa with abundances 
significantly different between CD and control samples. 
When more than one sample was available from the 
same patient for analysis, the log relative abundances 
from these samples were averaged.
It has been shown that variations in species 
abundance are better captured by a log­transformed 
than a linear scale, improving the statistical power[13]. 
Therefore, we followed this approach. In addition, 
rare taxa (< 1% abundance or absent from > 50% of 
the samples) were removed to improve the statistical 
power. Statistical significance was assessed via a 
permutation test (Fisher’s exact test), which yielded 
raw, uncorrected P­values. These were transformed 
into q­values (corrected P­value) that measure the 
probability of false discovery following the Benjamini 
Hochberg procedure[17]. We considered associations 
statistically significant only when the corrected P­values 
were less than 0.05. 
A linear logistic regression classifier (linearmodel.
LogisticRegression) in scikit­learn, Machine Learning in 
Python[16], was used to predict CD based on the subject’s 
microbiota. The accuracy of the classifier was tested by 
computing the receiver operating characteristic (ROC) 
curve with 5­fold stratified cross­validation under 100 
permutations of the training data partition. We partitioned 
the data into randomly assigned training and test sets 
100 times; in each case, the classifier was trained on 
4/5 of the data and tested on 1/5 of the data (i.e. 5­fold 
cross­validation).
Alpha diversity, a measure of genera richness 
(number of genera), was evaluated using the Shannon 
index. We used Fisher’s t­test to determine P­values for 
alpha diversity.
The difference in community composition (Beta 
diversity) was quantified by the Bray­Curtis distance, 
which accounts for both patterns of presence­absence 
of taxa and changes in their relative abundances. 
Nonparametric multidimensional scaling (NMDS) was 
applied to visualize the distance between mucosa and 
stool samples taken from CD and control subjects. NMDS 
quantifies the dissimilarity in community composition 
between samples via a combination of presence­absence 
and absolute abundance of taxa. For the data shown, the 
separations were analyzed by the ANOSIM or analysis of 
(dis)similarity. The ANOSIM statistic compares the mean 
of ranked dissimilarities between groups to the mean of 
ranked dissimilarities within groups. 
The statistical analyses in this article were performed 
and reviewed by the coauthors Kirill S Korolev, PhD and 
Rajita Menon, PhD from the Bioinformatics Program, 
Boston University, Boston, MA, United States. 
RESULTS
Demographic data
All children were Saudi nationals. There were 15 CD 
children and 20 controls; mean age was 13.9 (range: 
6.7­17.8) years for CD children and 13.9 (3.25­18.6) 
years for controls, and 10/15 (67%) of the CD and 13/20 
(65%) of the control subjects were boys. At diagnosis, 
CD locations were ileal (L1) in 4 and ileocolonic (L3) in 11 
children, while CD behavior was non­stricturing and non­
penetrating (B1) in 12 and stricturing (B2) in 3 children. 
Controls included all patients with no evidence of IBD 
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indicating that only two species, Volvariella dunensis (P = 
0.03) and Lepraria humida (P = 0.04), were significantly 
less abundant in stool than in mucosal samples. In 
contrast, about 50 species were significantly less 
abundant in stools of children with CD (P < 0.05) and 
only two species, Saccharomyces cerevisiae (P = 0.02) 
and S. bayanus (P = 0.001), were significantly more 
abundant in stools than in mucosal samples (Table 2). 
Alpha diversity, as measured by the Shannon Index and 
illustrated in Figure 2, was different in mucosa and stool. 
The stool community for children with CD was more than 
5 times less diverse than that of mucosa (P = 0.0001), 
whereas in controls the reduction in stool diversity was 
statistically not significant (P = 0.35). Beta diversity, as 
measured by the Bray­Curtis distance and visualized by 
the NMDS in Figure 3, shows a significant difference in 
fungal community separation between mucosal and stool 
samples (P = 0.005). 
DISCUSSION
Microbial dysbiosis in the form of depletion of beneficial 
organisms, expansion of harmful organisms, and 
reduced microbial diversity may occur independently or 
concurrently and result in significant effects on immune 
responses[18]. Fungal dysbiosis demonstrated in Saudi 
children with CD is in line with previous studies[19,20].
Key findings
This is the first report on the accuracy of fungal 
dysbiosis in mucosa and stools in predicting the 
diagnosis of CD in children. The main finding in this 
study is the high AUC for the fungal dysbiosis classifier, 
suggesting high accuracy in predicting the diagnosis 
of CD, which is in line with the high AUC for bacterial 
dysbiosis[11­13]. However, the higher AUC for the fungal 
dysbiosis classifier is in stool (0.85 ± 0.057) rather 
than in mucosa (0.71 ± 0.067) (P < 0.001), in contrast 
with the higher AUC for bacterial dysbiosis in mucosal 
samples[12­13]. Since this is the first report on fungal 
dysbiosis accuracy in predicting the diagnosis of CD, 
further studies are needed to clarify this result. 
The finding of significant differences in a large 
number of species between stool and mucosa in CD 
children compared to much smaller numbers of species 
in controls reflects the degree of disturbance of the fungal 
community in children with CD. In this study, except for 
S. cerevisiae and S. bayanus, which were significantly 
more abundant in stool samples (P = 0.02 and P = 0.003, 
respectively), the significantly lower abundance of most 
fungal species in stool than in mucosal samples indicates 
or other causes of inflammation. The final diagnoses 
in control subjects were juvenile polyps, recurrent 
abdominal pain, recurrent cyclic vomiting or other 
functional gastrointestinal disorders.
Fungal dysbiosis
In a previous report, description of fungal community 
structure in mucosa and stool in children with CD 
relative to controls indicated significantly-abundant CD-
associated taxa included Psathyrellaceae (P = 0.01), 
Cortinariaceae (P = 0.04), Psathyrella (P = 0.003), 
and Gymnopilus (P = 0.03). Monilinia was significantly 
depleted (P = 0.03), whereas other depleted 
taxa, although not statistically significant, included 
Leotiomycetes (P = 0.06), Helotiales (P = 0.08), and 
Sclerotiniaceae (P = 0.07)[10]. 
Prediction analysis
The mean area under the ROC curve (AUC) for the 
fungal dysbiosis classifier is illustrated in Figure 1, 
indicating a significantly­higher AUC in stools (0.85 ± 
0.057) than in mucosa (0.71 ± 0.067) (P < 0.001). 
This analysis was further expanded to demonstrate 
the difference in abundance and diversity between 
mucosa and stool in controls and children with CD 
separately. Table 1 shows a comparison of fungal 
abundance between mucosa and stools in controls, 
Table 1  Fungal species abundance in mucosa and stool of controls
Fungal species Mucosa abundance, % Stool abundance, % Ratio P  value
Volvariella dunensis 0.027 0.0013 0.047 0.036
Lepraria humida 0.015 0.0010 0.063 0.042
0.0           0.2           0.4          0.6           0.8          1.0
False positive rate
1.0
0.8
0.6
0.4
0.2
0.0
Tr
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Stool (AUC = 0.85 ± 0.057)
Mucosa (AUC = 0.71 ± 0.067)
Figure 1  Dysbiosis score classification curve to distinguish between 
children with Crohn’s disease and controls. The receiver operating 
characteristic (ROC) curve demonstrated the logistic regression dysbiosis 
classifier. The mean ROC curve for stool (solid black line) and mucosal (solid 
red line) dysbiosis scores in fungi cohorts is shown. The standard deviation 
from 100 permutations is shown in gray and light red shading. The area under 
the curve for stool dysbiosis is significantly higher than in mucosal dysbiosis, 
using a Fisher’s t-test computed P < 0.001.
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variation in dysbiosis between stools and mucosa and 
supports the variable accuracy in predicting the diagnosis 
of CD.
It has been suggested that the presence of some fungi 
in the gut may reflect environmental exposure, rather 
than colonization of the mucosa[21]. However, reports 
indicate that many fungi, such as Candida, Cryptococcus, 
Malassezia, Saccharomyces and Trichosporon spp, have 
been isolated from the stool of humans[22,23]. Furthermore, 
the role of fungi in the pathogenesis of IBD has been 
suggested based on animal models of colitis. Pattern 
recognition receptors in the innate immune system cells 
include dectin­1, dectin­2, DC­SIGN, mannose receptor, 
and mannose receptor lecithin[24], and mice lacking 
dectin­1 had increased susceptibility to experimental 
colitis[25]. In addition, treatment with antifungal drugs may 
Table 2  Fungal species abundance in mucosa and stool of children with Crohn’s disease
Fungal species Mucosa abundance, % Stool abundance, % Ratio P  value
Volvariella dunensis  0.06 0.0014 0.025 < 0.001
Malassezia restricta 0.09 0.0044 0.049 < 0.001
Ceriporia lacerate 0.03 0.0022 0.065 < 0.001
Cl. Cladosporioides 0.11 0.004 0.035 < 0.001
Trametes hirsute 0.048 0.0043 0.089 < 0.001
Psathyrella artemisiae 0.44 0.028 0.065 < 0.001
Amyloporia sp 0.027 0.0012 0.046 < 0.001
Irpex sp 0.095 0.0019 0.02 < 0.001
Bjerkandera adusta 0.022 0.0011 0.049 < 0.001
Lepista sordida 0.041 0.0015 0.037 < 0.001
Cerrena sp 0.022 0.0011 0.05 < 0.001
Coprinellus radians 0.034 0.0011 0.032 < 0.001
Phlebia acanthocystis 0.022 0.0011 0.048 < 0.001
Leptosphaerulina sp 0.037 0.0013 0.036 < 0.001
Coprinus sp 0.085 0.0019 0.022 < 0.001
Malassezia globose 0.028 0.0026 0.095 < 0.001
Alternaria alternate 0.054 0.0037 0.069 < 0.001
Ramalinopsis mannii 0.066 0.0018 0.027 < 0.001
Saccharomyces bayanus 2.5 53 21 < 0.001
Trichoderma hypocrea   0.022 0.0014 0.067 < 0.001
Aspergillus penicillioides 0.11 0.0066 0.062 < 0.001
Psathyrella candolleana 0.063 0.0059 0.093 < 0.001
Cladosporium sp 0.072 0.0053 0.074 < 0.001
Aspergillus sp 0.064 0.0049 0.076 < 0.001
Galactomyces geotrichum 0.079 0.0063 0.08 < 0.001
Peniophora incarnate 0.011 0.0027 0.25 < 0.001
Eutypella sp 0.038 0.0044 0.12 < 0.001
Ophiocordyceps sinensis 0.059 0.004 0.068 < 0.001
Nakaseomyces candida 0.12 0.0058 0.049 0.019
Hypocrea ceramic 0.02 0.0037 0.18 0.019
Saccharomyces cerevisiae 0.043 0.23 5.3 0.024
Mucosa                            Stool
2.5
2.0
1.5
1.0
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0.0
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Figure 2  Alpha diversity evaluated by the Shannon Index. Comparison between mucosa and stool in children with Crohn’s disease (CD) and controls. Alpha 
diversity is significantly lower in stool than in mucosa in CD samples (P = 0.0001), while the difference is not significant in control samples (P = 0.35).
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reduce the inflammation[26]. 
Strengths and weaknesses of this study
The strengths of this study comprise the facts that 
it is the first to investigate the subject and provides 
inclusion of newly­diagnosed, treatment­naïve children 
with CD and controls from a well­defined population. 
Weaknesses include the relatively small number of 
cases which may be adequate for a first report. The 
controls were not completely healthy. Obviously, 
performing endoscopy and biopsies to exclude IBD in 
healthy children is unethical. Therefore, children who 
are free of IBD, infection and inflammation have been 
considered appropriate non­IBD controls.
In conclusion, the most important finding in this 
study is the high AUC in fecal samples of children 
with CD, suggesting high accuracy in predicting the 
diagnosis. Although, the clinical application of this 
finding is limited at present by the high cost of fungal 
analysis, such information is important from a scientific 
viewpoint, to increase the understanding of the role of 
fungal flora in CD and to stimulate further research, 
possibly leading to a “dysbiosis test” as a noninvasive 
screening tool for CD. 
ARTICLE HIGHLIGHTS
Research background
Bacterial dysbiosis has been reported to predict the diagnosis of Crohn’
s disease (CD), but no similar reports for fungal dysbiosis exist. The study 
is of scientific significance to stimulate further research important for further 
clarification of the role of fungi in CD.
Research motivation
The role of microbiota in CD, bacterial or fungal, is of worldwide research 
interest. However, a key problem to be solved is whether dysbiosis is the cause 
or the result of inflammation. Solving this problem may facilitate discovery of 
new microbiota-based treatment options. Regarding the accuracy of fungal 
dysbiosis in predicting the diagnosis, the main problem would be the current 
high cost of fungal analysis. Solving this problem could lead to development of 
a dysbiosis screening test for CD. 
Research objectives
The objective of this study was to evaluate the accuracy of intestinal fungal 
dysbiosis as a predictor of CD. High accuracy was found. Future research is 
needed to confirm this finding and to develop low-cost fungal dysbiosis tests. 
Research methods
Mucosal and stool samples were collected from children with CD at presentation 
and controls. Fungal DNA was extracted from theses samples and sequencing 
was performed. Fungal abundance and diversities were determined. Fungal 
dysbiosis in children with CD was demonstrated. This is the first study of the 
accuracy of fungal dysbiosis in predicting the diagnosis of CD in children. 
Research results
The main finding was the high accuracy of fungal dysbiosis in predicting 
diagnosis of CD. This should stimulate further research to confirm our findings 
and to develop a low-cost dysbiosis test. 
Research conclusions
The high accuracy of fungal dysbiosis in predicting the diagnosis of CD is a new 
finding. The finding could lead to further research in the role of fungal dysbiosis 
in CD. A new theory suggests the possibility of design of a noninvasive fungal 
dysbiosis screening test for CD. 
Research perspectives
The role of microbiota in CD may include development of a noninvasive 
screening test. Further research is needed to confirm the findings and to 
develop low-cost fungal analysis. 
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